Sinusitis in immunodeficient and immunosuppressed patients.

Area of Science:

• Medical Mycology
• Infectious Diseases
• Immunology

Background:

• Sinusitis is a significant complication in immunocompromised individuals, particularly during severe leukopenia.
• Patient groups at high risk include those with primary immunodeficiency diseases, leukemia undergoing chemotherapy, and transplant recipients (bone marrow, kidney).

Purpose of the Study:

• To highlight the occurrence and potential severity of sinusitis in immunocompromised patients.
• To emphasize the diagnostic challenges posed by minimal initial clinical and radiographic signs.
• To underscore the critical need for prompt recognition and management of aggressive fungal or bacterial sinusitis.

Main Methods:

• Review of clinical observations and case histories of sinusitis in immunocompromised patients.
• Analysis of causative pathogens, including Aspergillus, Phycomycetes, and Pseudomonas.
• Correlation of clinical presentation with radiographic findings.

Main Results:

• Sinusitis presents a considerable risk in patients with severe leukopenia due to various immunosuppressive conditions.
• Clinical and radiographic signs of sinusitis can be subtle or deceptively mild in this population.
• Infections caused by Aspergillus, Phycomycetes, or Pseudomonas can progress rapidly and be life-threatening.

Conclusions:

• Immunocompromised patients with severe leukopenia are prone to sinusitis, which may present insidiously.
• Early and aggressive management, including extensive surgical procedures, is crucial for controlling potentially fatal fungal or bacterial sinusitis in this vulnerable group.